Logo image
IRO Home Research units Researcher Profiles
Sign in
What's hot, what's not, in dementia drugs. Part II
Journal article   Peer reviewed

What's hot, what's not, in dementia drugs. Part II

Kathleen Buckwalter
Journal of gerontological nursing, Vol.23(12), pp.46-47
12/1997
DOI: 10.3928/0098-9134-19971201-11
PMID: 9460415

View Online

Abstract

Research is dramatically increasing our understanding of what goes awry in the brains of persons with AD. Three compounds approved for use in other conditions, estrogen, anti-inflammatory drugs, and antioxidants, are currently under study based on their ability to promote cell metabolism and survival, counteract inflammatory responses, and protect neurons from oxidative damage. All three show promise in terms of treating and possibly preventing Alzheimer's disease.

Nursing Alzheimer Disease/drug therapy Anti-Inflammatory Agents Non-Steroidal/therapeutic use Antioxidants/therapeutic use Estrogens/therapeutic use Humans

Details

Metrics

44 Record Views
Logo image